The purpose of the contract is to clean up areas requiring specific technical requirements and authoritations within the premises of EFS Île-de-France: the pharmaceutical platform of EFS Île-de-France in Créteil constitutes a reference site for the production and quality control of Innovative Therapy Medicines (MTI) in the framework of trials Phase I, II and III clinics.

It integrates into its environment the cellular therapy activities and tissue bank of EFS Île-de-France, the Molecular Immuno-Hematology Laboratory of Créteil which is one of the three reference laboratories and the HLA-ILP laboratory.

The purpose of the contract is to clean up areas requiring specific technical requirements and authoritations within the premises of EFS Île-de-France: the pharmaceutical platform of EFS Île-de-France in Créteil constitutes a reference site for the production and quality control of Innovative Therapy Medicines (MTI) in the framework of trials Phase I, II and III clinics.

It integrates into its environment the cellular therapy activities and tissue bank of EFS Île-de-France, the Molecular Immuno-Hematology Laboratory of Créteil which is one of the three reference laboratories and the HLA-ILP laboratory.